Croda International Valuation

Is CRDA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CRDA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CRDA (£34.62) is trading above our estimate of fair value (£26.75)

Significantly Below Fair Value: CRDA is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for CRDA?

Key metric: As CRDA is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for CRDA. This is calculated by dividing CRDA's market cap by their current earnings.
What is CRDA's PE Ratio?
PE Ratio29.7x
EarningsUK£162.70m
Market CapUK£4.83b

Price to Earnings Ratio vs Peers

How does CRDA's PE Ratio compare to its peers?

The above table shows the PE ratio for CRDA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average24x
JMAT Johnson Matthey
24x28.4%UK£2.6b
VCT Victrex
24.4x37.8%UK£749.6m
TET Treatt
22.7x15.3%UK£256.6m
FRES Fresnillo
24.7x33.0%UK£4.9b
CRDA Croda International
29.7x15.1%UK£4.8b

Price-To-Earnings vs Peers: CRDA is expensive based on its Price-To-Earnings Ratio (29.7x) compared to the peer average (24x).


Price to Earnings Ratio vs Industry

How does CRDA's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
CRDA 29.7xIndustry Avg. 17.1xNo. of Companies11PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: CRDA is expensive based on its Price-To-Earnings Ratio (29.7x) compared to the European Chemicals industry average (17.9x).


Price to Earnings Ratio vs Fair Ratio

What is CRDA's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CRDA PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio29.7x
Fair PE Ratio18.3x

Price-To-Earnings vs Fair Ratio: CRDA is expensive based on its Price-To-Earnings Ratio (29.7x) compared to the estimated Fair Price-To-Earnings Ratio (18.3x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CRDA forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUK£34.62
UK£45.36
+31.0%
11.0%UK£55.00UK£38.75n/a16
Nov ’25UK£37.71
UK£46.40
+23.0%
10.7%UK£55.00UK£38.75n/a16
Oct ’25UK£41.95
UK£46.94
+11.9%
10.1%UK£55.00UK£41.00n/a16
Sep ’25UK£41.07
UK£46.77
+13.9%
10.3%UK£55.00UK£41.00n/a15
Aug ’25UK£39.67
UK£47.33
+19.3%
10.0%UK£55.00UK£41.00n/a15
Jul ’25UK£38.99
UK£49.53
+27.0%
9.3%UK£57.00UK£41.00n/a15
Jun ’25UK£45.40
UK£50.13
+10.4%
8.7%UK£57.00UK£41.00n/a15
May ’25UK£46.19
UK£50.13
+8.5%
8.7%UK£57.00UK£41.00n/a15
Apr ’25UK£49.02
UK£49.67
+1.3%
8.7%UK£56.00UK£41.00n/a15
Mar ’25UK£48.98
UK£49.07
+0.2%
9.1%UK£56.00UK£41.00n/a15
Feb ’25UK£49.67
UK£49.65
-0.03%
10.1%UK£59.00UK£41.00n/a15
Jan ’25UK£50.50
UK£51.67
+2.3%
10.0%UK£63.00UK£44.00n/a15
Dec ’24UK£44.80
UK£52.53
+17.3%
11.1%UK£63.00UK£44.00n/a15
Nov ’24UK£43.17
UK£52.80
+22.3%
11.0%UK£63.00UK£44.00UK£37.7115
Oct ’24UK£49.15
UK£62.13
+26.4%
9.4%UK£72.00UK£50.00UK£41.9516
Sep ’24UK£55.56
UK£63.12
+13.6%
8.8%UK£72.00UK£50.00UK£41.0717
Aug ’24UK£58.06
UK£63.71
+9.7%
11.0%UK£78.00UK£50.00UK£39.6717
Jul ’24UK£56.26
UK£66.71
+18.6%
11.6%UK£78.00UK£50.00UK£38.9917
Jun ’24UK£61.40
UK£76.17
+24.0%
11.4%UK£88.00UK£54.00UK£45.4018
May ’24UK£69.80
UK£76.94
+10.2%
11.0%UK£88.00UK£54.00UK£46.1918
Apr ’24UK£64.98
UK£76.89
+18.3%
11.0%UK£88.00UK£54.00UK£49.0218
Mar ’24UK£65.70
UK£79.71
+21.3%
12.7%UK£104.45UK£54.00UK£48.9819
Feb ’24UK£69.54
UK£79.97
+15.0%
12.5%UK£104.45UK£54.00UK£49.6719
Jan ’24UK£66.04
UK£80.87
+22.4%
12.6%UK£104.45UK£54.00UK£50.5019
Dec ’23UK£69.22
UK£80.81
+16.7%
12.5%UK£104.45UK£54.00UK£44.8019
Nov ’23UK£66.96
UK£81.50
+21.7%
13.1%UK£104.45UK£54.00UK£43.1719

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies